US OptionsDetailed Quotes

ALEC240719C5000

Watchlist

0.90
+0.20+28.57%

15min DelayClose Jul 12 15:59 ET

0.90High0.40Low

Alector Stock Discussion

Moomoo AI

Jan 19 13:58

Alector's low P/S ratio may be due to poor revenue performance and expectations of this trend continuing. Future revenue growth is expected to be significantly lower than the industry, possibly causing discomfort among shareholders and a drop in share price.

Little Excitement Around Alector, Inc.'s (NASDAQ:ALEC) Revenues As Shares Take 27% Pounding

Moomoo AI

Dec 12, 2023 06:41

Arnon Rosenthal's major sale indicates insiders may expect a lower price. Despite high insider ownership, the absence of insider purchases and significant sales stirs uncertainty about the company's prospects and arouses investor caution.

Alector Insiders Sell US$711k Of Stock, Possibly Signalling Caution

Moomoo AI

Oct 20, 2023 05:26

Despite declining revenue, Alector's cash runway looks promising. However, significant cash burn could necessitate capital raise, potentially diluting shareholder value. Risk factors warrant careful scrutiny before investment.

Is Alector (NASDAQ:ALEC) In A Good Position To Deliver On Growth Plans?

Best squeeze by end of July

$SoFi Technologies(SOFI.US)$
$Alector(ALEC.US)$
$PacWest Bancorp(PACW.US)$
Who will squeeze best?

JonSnow

Jun 6, 2023 18:19

Interesting

$Alector(ALEC.US)$
All in or just a little?

Movers and Shakers

Oct 3, 2022 07:18

ColumnsToday's Pre-Market Stock Movers: TSLA, CS, VOD, MYOV and More

Gapping up
$Viasat(VSAT.US)$ +5.9% (the Wall Street Journal reported that the satellite company was close to a deal to sell a military communications unit to defense contractor $L3Harris Technologies(LHX.US)$ for nearly $2 billion.)
$Myovant Sciences(MYOV.US)$ +31.3% (the biopharmaceutical company rejected a bid by its largest shareholder, Sumitovant Biopharma, to buy the shares it doesn’t already own for $22.75 per share. Myovant said...

Moomoo Breakfast US

Apr 13, 2022 07:38

ColumnsToday's pre-market stock movers: DAL, JPM, NSTG, ATRS and more

Gainers:
• $Antares Pharma(ATRS.US)$ +48.7% (to be acquired by Halozyme (HALO) for $5.60 per share)
• $Sierra Oncology(SRRA.US)$ +37.9% (acquired by GSK for $55 per share)
• $Amryt Pharma(AMYT.US)$ +11.7% (announces positive long-term safety and efficacy data for Mycapssa (oral octreotide) from the 2nd Year of OPTIMAL open label extension study in acromegaly patients)
• $BriaCell Therapeutics(BCTX.US)$ +6% (presents development details of...

Analysts Notebook

Apr 13, 2022 05:45

ColumnsTop upgrades and downgrades on 4/13

Upgrades
• $Booz Allen Hamilton Holding Corp(BAH.US)$: Goldman Sachs Upgrades to Buy from Neutral - PT $102 (from $83)
• $Humana(HUM.US)$: UBS Upgrades to Buy from Neutral - PT $520 (from $486)
• $JB Hunt Transport Services(JBHT.US)$: Deutsche Bank Upgrades to Buy from Hold - PT $230 (from $210)
Downgrades
• $JB Hunt Transport Services(JBHT.US)$: B.Riley Downgrades to Neutral from Buy - PT $33 (from $62)
• $CACI International(CACI.US)$: Goldman Sachs Downgrad...

No comment yet